林倩伃

職稱科副主任

專長頭頸部腫瘤、鼻咽癌
學歷1991.09-1998.06 畢業於中山醫學院
2004.07-2005.06 長庚大學臨床醫學研究所 碩士
2005.06-2012.02 長庚大學臨床醫學研究所 博士
經歷1998~2001 住院醫師, 林口長庚醫院放射腫瘤科
2001~2002 總住院醫師, 林口長庚醫院放射腫瘤科
2003~2003 主任醫師, 借調羅東博愛醫院放射腫瘤科
2003~2003 主任醫師, 借調苗栗為恭醫院放射腫瘤科
2002~2008 一般級主治醫師, 林口長庚醫院放射腫瘤科
2002~2008 講師級主治醫師, 林口長庚醫院放射腫瘤科
2002~2008 助理教授級主治醫師, 林口長庚醫院放射腫瘤科
2010~2015 兼任講師, 長庚大學 醫放系
2015~2020 兼任助理教授, 長庚大學 醫放系


參與學會台灣放射腫瘤學會
發表論文First Author and Corresponding Author
  • Cheng NM, Hsieh CE, Fang YD, Liao CT, Ng SH, Wang HM, Chou WC, Lin CY*, Yen TC*. (2020, 07) Development and validation of a prognostic model incorporating [18F]FDG PET/CT radiomics for patients with minor salivary gland carcinoma. EJNMMI Res. 10(1):74. doi: 10.1186/s13550-020-00631-3. (共同責任作者)
  • Lin CY#, Fan KH#, Lee LY#, Hsueh C, Yang LY, Ng SH, Wang HM, Hsieh CH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Lee LA, Huang SF, Chang KP, Yen TC, Tay ZY, Wen YW, Lee SR, Liao CT. (2020, 04) Precision Adjuvant Therapy Based on Detailed Pathological Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long Term Outcome Comparison of CGMH and NCCN Guidelines. Int J Radiat Oncol Biol Phys. 106(5):916-925. doi: 10.1016/j.ijrobp.2019.08.058. Epub 2019 Sep 6. (共同第一作者) 
  • Tsai CK#, Lin CY#, Kang CJ, Liao CT, Wang WL, Chiang MH, Yen TC, Lin G. (2020, 03) Nuclear Magnetic Resonance Metabolomics Biomarkers for Identifying High Risk Patients with Extranodal Extension in Oral Squamous Cell Carcinoma. J Clin Med. 9(4). pii: E951. doi: 10.3390/jcm9040951. (共同第一作者)
  • Cheng NM*, Hsieh CE, Liao CT, Ng SH, Wang HM, Fang YD, Chou WC, Lin CY*, Yen TC*. (2019, 05) Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology. Clin Nucl Med. 44(5):351-358. (共同責任作者)
  • Hsieh CE, Cheng NM, Chou WC, Venkatesulu BP, Chou YC, Liao CT, Yen TC, Lin CY*. (2018, 12) Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma. Clin Nucl Med. Clin Nucl Med. 43(12):869-879. 
  • Hsieh CE, Lee LY, Chou YC, Fan KH, Tsang NM, Chang JT, Wang HM, Ng SH, Liao CT, Yen TC, Fang KH, Lin CY*. (2018, 09) Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy - a multicenter experience. Radiat Oncol. 13(1):184.
  • Hsieh CE, Ho KC, Hsieh CH, Yen TC, Liao CT, Wang HM, Lin CY*. (2017, 9) Pretreatment Primary Tumor SUVmax on 18F-FDG PET/CT Images Predicts Outcomes in Patients With Salivary Gland Carcinoma Treated With Definitive Intensity-Modulated Radiation Therapy. Clin Nucl Med. 42(9):655-662. (責任作者)
  • Hsieh CE, Lin CY*, Lee LY, Yang LY, Wang CC, Wang HM, Chang JT, Fan KH, Liao CT, Yen TC, Fang KH, Tsang YM*. (2016, 3) Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study. Radiat Oncol. 11(1):47. doi: 10.1186/s13014-016-0617-7. (共同責任作者)
  • Kang CJ#, Lin CY#, Yang LY, Ho TY, Lee LY, Fan KH, Wang HM, Huang SF, Chang KP, Fang KH, Ng SH, Liao CT*, Yen TC*. (2015, 1) Positive Clinical Impact of an Additional PET/CT Scan Before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma. J Nucl Med. 56(1):22-30. (共同第一作者)
  • Liao CT#, Lin CY#, Fan KH, Hsueh C, Lee LY, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Lin CH, Huang YC, Yen TC*. (2013, 1) Outcome Analyses of Unusual Site Neck Recurrence in Oral Cavity Cancer. Ann Surg Oncol. 20(1):257-66. (共同第一作者) 
  • Liao CT#, Fan KH, Lin CY#, Wang HM*, Huang SF, Chen IH, Kang CJ, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC*. (2012, 6) Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread. Eur J Nucl Med Mol Imaging. 39(6):944-55. (共同第一作者) 
  • Lin CY, Lin TY, Wang HM, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Li YL, Chen YJ, Cheng AJ*, Chang JT*. (2011, 10) GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy. Radiat Oncol. 12;6(1):136. (第一作者)
  • Chiu CC#, Lin CY#, Lee LY, Chen YJ, Lu YC, Wang HM, Liao CT, Chang JT, Cheng AJ*. (2011, 7) Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer. Clin Cancer Res. 15;17(14):4629-41. (共同第一作者) 
  • Lin CY, Wang HM, Kang CJ, Lee LY, Huang SF, Fan KH, Chen EYC, Chen IH, Liao CT, Chang JT*. (2010, 11) Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced stage oral cavity cancers. Int J Radiat Oncol Biol Phys. 78(4):1011-9. (第一作者)
  • Lin CY, Chen WH, Liao CT, Chen IH, Chiu CC, Lee LY, Wang HM, Chang JT, Yen TC, Cheng AJ*. (2010, 8) Positive association of GRP78 during oral cancer progression and the prognostic value in oral precancer lesions. Head Neck. 32:1028-39. (第一作者)
  • Lin CY, Li YL, Huang SF, Kang CJ, Fan KH, Wang HM, Chen YC, Chen IH, Liao CT, Cheng AJ, Chang JT*. (2008, 4) Treatment outcome of combined modalities for buccal cancers - unilateral or bilateral neck radiation? Int J Radiat Oncol Biol Phys. 70: 1373-81. (第一作者)
  • Lin CY, Li SH, Chen LH, Hong JH, Chang JT*. (2000, 6) Junction techniques for pharynx and neck treatment. Therapeut Radiol Oncol 7: 77-87. (第一作者) 

Co-author

  • 1. Lin CH, Chou WC, Wu YY, Lin CY, Chang KP, Liao CT, Ho TY, Yeh CM, Liu CJ, Hung SP, Lee CH, Chen PJ, Chou YC, Fan KH, Huang BS, Tung-Chieh Chang J, Wang CC, Tsang NM. (2020, 09) Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study. Radiother Oncol. 154:76-86. doi: 10.1016/j.radonc.2020.09.012. Online ahead of print.
  • 2. Lin CR, Fan KH, Lin CY, Hung TM, Huang BS, Chen EY, Kang CJ, Huang SF, Chang JT*, Chang CH*. (2020, 08) Development and evaluation of a computerized clinical outcome assessment tool for head and neck cancer patients. Medicine (Baltimore). 99(34):e20304.
  • 3. Chiang YY, Chou YC, Chang KP, Liao CT, Wu YY, Yap WK, Pai PC, Chang JT, Lin CY, Fan KH, Huang BS, Hung TM, Tsang NM. (2020, 08) Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma. Radiat Oncol. 15(1):194. doi: 10.1186/s13014-020-01632-1.
  • 4. Hung TM, Fan KH, Kang CJ, Huang SF, Lin CY, Ho AT, Wang HM, Hsieh JC, Cheng AJ, Ng SH, Chang JT*. (2020, 07) Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma. Oral Oncol. 8;110:104756. doi: 10.1016/j.oraloncology.2020.104756. Online ahead of print.
  • 5. Lin HC, Chan SC, Cheng NM, Liao CT, Hsu CL, Wang HM, Lin CY, Chang JT, Ng SH, Yang LY, Yen TC. (2020, 05) Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma. Oral Oncol. 104:104628. doi: 10.1016/j.oraloncology.2020.104628. Epub 2020 Mar 9.
  • 6. Yeh CH, Chan SC, Lin CY, Yen TC, Chang JT, Ko SF, Fan KH, Wang HM, Liao CT, Ng SH. (2020, 01) Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 47(1):94-104. doi: 10.1007/s00259-019-04510-5.
  • 7. Hsieh CH, Lin CY, Hsu CL, Fan KH, Huang SF, Liao CT, Lee LY, Ng SK, Yen TC, Chang JT, Lin JR, Wang HM*. (2020, 1) Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial. J Cancer Res Clin Oncol. 146(1):33-41. doi: 10.1007/s00432-019-03033-8. Epub 2019 Nov 14.
  • 8. Liao CT, Hsieh CH, Fan WL, Ng SH, Cheng NM, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Lin CH, Tsao CK, Kang CJ, Fang TJ, Huang SF, Chang KP, Lee LA, Fang KH, Wang YC, Yang LY, Yen TC. (2020, 1) A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 47(1):84-93. doi: 10.1007/s00259-019-04453-x. Epub 2019 Aug 6.
  • 9. Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Ng SH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Huang SF, Chang KP, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yang LY, Yen TC. (2019, 10) Tumor Depth of Invasion (Tumor > 4 cm/Depth > 10 mm and Depth > 20 mm) and Through Cortex/Skin Invasion are Both Valid Criteria for Classifying Tumors as pT4a in AJCC 2018 Oral Cavity Cancer Staging System. Ann Surg Oncol. 26(11):3663-3672.
  • 10. Lee LY, De Paz D, Lin CY, Fan KH, Wang HM, Hsieh CH, Lee LA, Yen TC, Liao CT, Yeh CH, Kang CJ. (2019, 10) Prognostic impact of extratumoral perineural invasion in patients with oral cavity squamous cell carcinoma. Cancer Med. 8(14):6185-6194. 
  • 11. Chen SC, Huang BS, Hung TM, Lin CY, Chang YL. (2019, 09) Impact of physical and psychosocial dysfunction on return to work in survivors of oral cavity cancer. Psychooncology. 28(9):1910-1917. 
  • 12. Fan KH, Chao YK, Chang JT*, Tsang NM, Liao CT, Chang KP, Lin CY, Wang HM, Hsu CL, Huang SF. (2019, 08) A retrospective analysis of the treatment results for advanced synchronous head and neck and esophageal cancer. BJR|Open. https://doi.org/10.1259/bjro.20190015. Published Online: August 06, 2019.
  • 13. Wang HM, Wu MH, Chang PH, Lin HC, Liao CD, Wu SM, Hung TM, Lin CY, Chang TC, Tzu-Tsen Y, Hsieh JC. (2019, 08) The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer. Head Neck. 41(8):2676-2687. 
  • 14. Hsieh CE, Hung CY, Lin CY, Chen JS, Chang KP, Aithala SP, Lee LY, Tsang NM, Lu CH, Chen MF, Cheng YF, Yeh KY, Wang CH, Chou WC. (2019, 06) High metastatic node number, not extranodal extension, as a node-related prognosticator in surgically treated patients with nodal metastatic salivary gland carcinoma. Head Neck. 41(6):1572-1582.
  • 15. Cheng NM, Hsieh CE, Liao CT, Ng SH, Wang HM, Fang YD, Chou WC, Lin CY, Yen TC. (2019, 05) Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology. Clin Nucl Med. 44(5):351-358. 
  • 16. Chang YL, Huang BS, Hung TM, Lin CY, Chen SC. (2019, 05) Factors influencing body image in posttreatment oral cavity cancer patients. Psychooncology. 28(5):1127-1133. 
  • 17. Chen SC, Huang BS, Hung TM, Lin CY, Chang YL. (2019, 02) Impact of a behavior change program and health education on social interactions in survivors of head and neck cancer: Randomized controlled trial. Psychooncology. 28(2):293-300.
  • 18. Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Ng SH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Huang SF, Chang KP, Yang LY, Yen TC. (2018, 11) Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension. Oral Oncol. 86:188-194.
  • 19. Chen SC, Huang BS, Hung TM, Chang YL, Lin CY, Chung CY, Wu SC. (2018, 10) Swallowing ability and its impact on dysphagia-specific health-related QOL in oral cavity cancer patients post-treatment. Eur J Oncol Nurs. 36:89-94.
  • 20. Chen SC, Huang BS, Chung CY, Lin CY, Fan KH, Chang JT, Wu SC. (2018, 08) Effects of a swallowing exercise education program on dysphagia-specific health-related quality of life in oral cavity cancer patients post-treatment: a randomized controlled trial. Support Care Cancer. 26(8):2919-2928.
  • 21. Chan SC, Yeh CH, Yen TC, Ng SH, Chang JT, Lin CY, Yen-Ming T, Fan KH, Huang BS, Hsu CL, Chang KP, Wang HM, Liao CT. (2018, 07) Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 45(8):1297-1308. 
  • 22. Pai PC, Chuang CC, Chuang WC, Tsang NM, Tseng CK, Chen KH, Yen TC, Lin CY, Chang KP, Lei KF. (2018, 05) Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan. Cancer Med. 7(5):1630-1641.
  • 23. Wu YY, Chang KP, Lin CY, Pai PC, Wang HM, Hsu CL, Liao CT, Yen TC, Fang TJ, Huang SF, Kang CJ, Fang KH, Lin WN, Wang YC, Hsin LJ, Tsang NM. (2018, 05) Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy. Cancer Med. 7(7):2808–2815. doi: 10.1002/cam4.1489. 
  • 24. Huang PW, Lin CY, Hsieh CH, Hsu CL, Fan KH, Huang SF, Liao CT, Ng SK, Yen TC, Chang JT*, Wang HM*. (2018, 04) A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx. Biomed J. 41(2):129-136. 
  • 25. Chen SC, Huang CY, Huang BS, Lin CY, Fan KH, Chang JT, Wu SC, Lai YH. (2018, 03) Factors associated with healthcare professional's rating of disfigurement and self-perceived body image in female patients with head and neck cancer. Eur J Cancer Care (Engl). 27(2):e12710.
  • 26. Huang BS, Wu SC, Lin CY, Fan KH, Chang JT, Chen SC. (2018, 03) The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial. Eur J Cancer Care (Engl). 2018 Mar;27(2):e12819.
  • 27. Chan SC, Cheng NM, Hsieh CH, Ng SH, Lin CY, Yen TC, Hsu CL, Wan HM, Liao CT, Chang KP, Wang JJ. (2018, 02) Correction: Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget. 9(11):10184. 
  • 28. Yeh CH, Lin G, Wang JJ, Lin CY, Tsai SY, Lin YC, Wu YM, Ko SF, Wang HM, Chan SC, Yen TC, Liao CT, Ng SH. (2017, 12) Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study. Oncotarget. 8(70):115513-115525. 
  • 29. Fan KH, Chen YC, Lin CY, Kang CJ, Lee LY, Huang SF, Liao CT, Ng SH, Wang HM, Chang JT*. (2017, 11) Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis. Radiat Oncol. 2017 Nov 22;12(1):184.
  • 30. Hsin LJ, Lin WN, Fang TJ, Lee LA, Kang CJ, Huang BS, Lin CY, Fan KH, Tsang NM, Hsu CL, Chang JT, Liao CT, Yen TC, Chang KP, Chuang HF, Li HY. (2017, 10) Life quality improvement in hoarse patients with early glottic cancer after transoral laser microsurgery. Head Neck. 39(10):2070-2078. 
  • 31. Chen SC, Huang BS, Lin CY, Fan KH, Chang JT, Wu SC, Lai YH. (2017, 9) Psychosocial Effects of a Skin Camouflage Program in the Female Survivors with Head and Neck Cancer: A Randomized Controlled Trial. Psychooncology. 26(9):1376-1383.
  • 32. Chou YC, Lin CY, Pai PC, Tseng CK, Hsieh CE, Chang KP, Hsu CL, Liao CT, Wang CC, Chin SC, Yen TC, Ho TY, Hong JH, Lei KF, Chang JT, Tsang NM. (2017, 9) Dose-escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score-matched study. Cancer Med. 6(9):2087-2097.
  • 33. Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Hsieh CH, Ng SH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Huang SF, Chang KP, Yang LY, Yen TC. (2017, 09) Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered? Ann Surg Oncol. 24(9):2570-2579.
  • 34. Lin HC, Kang CJ, Huang SF, Wang HM, Lin CY, Lee LY, Liao CT, Yen TC. (2017, 09) Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 44(10):1702-1711.
  • 35. Chen SC, Huang BS, Lin CY, Fan KH, Chang JT, Wu SC, Lai YH. (2017, 9) Psychosocial Effects of a Skin Camouflage Program in the Female Survivors with Head and Neck Cancer: A Randomized Controlled Trial. Psychooncology. 26(9):1376-1383.
  • 36. Fang TJ, Lee LA, Huang BS, Lin CY, Hsu CL, Chang JT, Yen TC, Liao CT, Chiang HC. (2017, 8) What should we expect from robotic surgery for second primary oropharyngeal cancer? Eur Arch Otorhinolaryngol. 274(8):3161-3168.
  • 37. Hung TM, Lin CR, Chi YC, Lin CY, Chen EY, Kang CJ, Huang SF, Juang YY, Huang CY*, Chang JT*. (2017, 8) Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures. Health Qual Life Outcomes. 15(1):165.
  • 38. Huang YH, Yeh CH, Cheng NM, Lin CY, Wang HM, Ko SF, Toh CH, Yen TC, Liao CT, Ng SH. (2017, 7) Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns. PLoS One. 12(7):e0180779. 
  • 39. Liao CT, Wen YW, Yang LY, Lee SR, Ng SH, Liu TW, Tsai ST, Tsai MH, Lin JC, Chen PR, Lou PJ, Wang CP, Chu PY, Hwang TZ, Leu YS, Tsai KY, Terng SD, Chen TM, Wang CH, Chien CY, Chen WC, Lee LY, Lin CY, Wang HM, Hsieh CH, Tsao CK, Fang TJ, Huang SF, Kang CJ, Chang KP, Yen TC. (2017, 4) Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas. Oral Oncol. 67:95-102.
  • 40. Chan SC, Cheng NM, Hsieh CH, Ng SH, Lin CY, Yen TC, Hsu CL, Wan HM, Liao CT, Chang KP, Wang JJ. (2017, 3) Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget. 8(37):62606-62621.
  • 41. Liao CT, Wen YW, Lee SR, Liu TW, Tsai ST, Tsai MH, Lin JC, Lou PJ, Chu PY, Leu YS, Tsai KY, Terng SD, Chen TM, Wang CH, Chien CY, Chen WC, Lee LY, Lin CY, Wang HM, Ng SH, Lin CH, Fang TJ, Huang SF, Kang CJ, Chang KP, Yang LY, Yen TC. (2017, 3) Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients. Ann Surg Oncol. 24(3):785-793.
  • 42. Wang HM, Lin CY, Hsieh CH, Hsu CL, Fan KH, Chang JT, Huang SF, Kang CJ, Liao CT, Ng SH, Yen TC. (2017, 3) Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer. J Formos Med Assoc. 116(3):185-192.
  • 43. Liao CT, Chen HN, Wen YW, Lee SR, Ng SH, Liu TW, Tsai ST, Tsai MH, Lin JC, Lou PJ, Wang CP, Chu PY, Leu YS, Tsai KY, Terng SD, Chen TM, Wang CH, Chien CY, Chen WC, Lee LY, Lin CY, Wang HM, Lin CH, Fang TJ, Huang SF, Kang CJ, Chang KP, Yang LY, Yen TC. (2017, 2) Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma. Eur J Cancer. 72:226-234. 
  • 44. Hung TM, Fan KH, Chen EY, Lin CY, Kang CJ, Huang SF, Liao CT, Ng SH, Wang HM, Chang JT* (2017, 2) An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a long-term follow-up result. Medicine (Baltimore). 96(6):e6036.
  • 45. Chang C, Lin WN, Hsin LJ, Lee LA, Lin CY, Li HY, Liao CT, Fang TJ. (2016, 12) Reliability of office-based narrow-band imaging-guided flexible laryngoscopic tissue samplings. Laryngoscope. 126(12):2764-2769. 
  • 46. Ng SH, Liao CT, Lin CY, Chan SC, Lin YC, Yen TC, Chang JT, Ko SF, Fan KH, Wang HM, Yang LY, Wang JJ. (2016, 11) Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. Eur Radiol. 26(11):4162-4172.
  • 47. Wang HM, Liao CT, Yen TC, Chen SJ, Lee LY, Hsieh CH, Lin CY, Ng SH. (2016, 9) Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension. Oncotarget. 7(39):63082-63092. 
  • 48. Huang BS, Chen WY, Hsieh CE, Lin CY, Lee LY, Fang KH, Tsang NM, Kang CJ, Wang HM, Chang JT*. (2016, 9) Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas. Jpn J Clin Oncol. 46(9):832-8. 
  • 49. Wang HM, Lin TL, Kuo YC, Li HP, Chang KP, Lin CY, Fan HC, Lin AC, Hsieh CH, Tsang NM, Lee LY, Chan SC, Lui KW, Chang YS, Hsu CL. (2016, 8) Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis. Oncotarget. 7(33):53217-53229. 
  • 50. Su YY, Chen SH, Hsieh CH, Liao CT, Lin CY, Kang CJ, Yen TC. (2016, 8) Defining risk groups of patients with cancer of unknown primary site and cervical nodal metastases by F-18 fluorodeoxyglucose positron emission tomography and computed tomography imaging. Kaohsiung J Med Sci 32(8 ):407-13.
  • 51. Chen SH, Wang HM, Lin CY, Chang JT, Hsieh CH, Liao CT, Kang CJ, Yang LY, Yen TC. (2016, 8) RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study. Eur J Nucl Med Mol Imaging. 43(9):1621-9.
  • 52. Lapke N, Lu YJ, Liao CT, Lee LY, Lin CY, Wang HM, Ng SH, Chen SJ, Yen TC. (2016, 7) Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma. Oncotarget. 12;7(28):44194-44210.
  • 53. Liao CT, Kang CJ, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Fang TJ, Huang SF, Chang KP, Chang YL, Yang LY, Yen TC. (2016, 4) Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma. Head Neck. 38 Suppl 1:E1544-53. 
  • 54. Adel M, Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Huang SF, Kang CJ, Fang KH, Wang YC, Chang KP, Fang TJ, Yang LY, Yen TC. (2016, 3) Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic Area. Medicine (Baltimore). 95(12):e2950.
  • 55. Liao CT, Chen SJ, Lee LY, Hsueh C, Yang LY, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Chang KP, Huang SF, Kang CJ, Chen HC, Yen TC. (2016, 2) An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma. Medicine (Baltimore). 95(8):e2751. 
  • 56. Chin SC, Lin CY, Huang BS, Tsang NM, Fan KH, Ku YK, Hsu CL, Chan SC, Huang SF, Li CH, Tseng HJ, Liao CT, Liu HL, Sung K. (2016, 2) Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma. Medicine (Baltimore). 95(6):e2567.
  • 57. Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL, Lee LY, Hsueh C, Lin CY, Fan KH, Chang TC, Wang HM, Ng SH, Yen TC. (2015, 11) Human Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer. Medicine (Baltimore). 94(47):e2069.
  • 58. Liao CT, Fan KH, Kang CJ, Lin CY, Chang JT, Tsang NM, Huang BS, Chao YK, Lee LY, Hsueh C, Wang HM, Liau CT, Hsu CL, Hsieh CH, Ng SH, Lin CH, Tsao CK, Fang TJ, Huang SF, Chang KP, Yen TC. (2015, 9) Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies. PLoS One. 10(9): e0136918.
  • 59. Chen SC*, Lai YH, Huang BS, Lin CY, Fan KH, Chang JT. (2015, 6) Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment. Eur J Oncol Nurs. 19(3):214-9.
  • 60. Huang SF, Tung-Chieh Chang J, Liao CT, Kang CJ, Lin CY, Fan KH, Wang HM, Chen IH. (2015, 1) The role of elective neck dissection in early stage buccal cancer. Laryngoscope. 125(1):128-33.
  • 61. Huang CG, Lee LA, Tsao KC, Liao CT, Yang LY, Kang CJ, Chang KP, Huang SF, Chen IH, Yang SL, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Chang TC, Wang HM, Ng SH, Yen TC. (2014, 10) Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma. J Clin Virol. 61(2):230-6. 
  • 62. Ng SH, Lin CY, Chan SC, Lin YC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Chang CJ, Wang JJ. (2014, 10) Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and 18F-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation. PLoS One. 9(12):e115933. 
  • 63. Liao CT, Wallace CG, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Huang SF, Kang CJ, Yen TC. (2014, 8) Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area. Oral Oncol. 50(8):721-31. 
  • 64. Wang HM, Hsu CL, Hsieh CH, Fan KH, Lin CY, Chang JT, Huang SF, Chen IH, Liao CT, Ng SK. (2014, 5-6) Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx. Biomed J. 37(3):133-40. 
  • 65. Chen SC, Lai YH, Liao CT, Huang BS, Lin CY, Fan KH, Chang JT. (2014, 5) Unmet supportive care needs and characteristics of family caregivers of patients with oral cancer after surgery. Psychooncology. 23(5):569-77.
  • 66. Lin CH, Kang CJ, Tsao CK, Wallace CG, Lee LY, Lin CY, Wang HM, Ng SH, Yen TC, Liao CT. (2014, 4) Priority of fibular reconstruction in patients with oral cavity cancer undergoing segmental mandibulectomy. PLoS One. 9(4):e94315. 
  • 67. Fang YH, Lin CY, Shih MJ, Wang HM, Ho TY, Liao CT, Yen TC. (2014, 3) Development and evaluation of an open-source software package "CGITA" for quantifying tumor heterogeneity with molecular images. Biomed Res Int. 2014:248505. 
  • 68. Hung TM, Chen CC, Lin CY, Ng SH, Kang CJ, Huang SF, Liao CT, Fan KH, Wang HM*, Chang JT*. (2014, 3) Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. Oral Oncol. 50(3):228-33.
  • 69. Fan KH, Lin CY, Kang CJ, Lee LY, Huang SF, Liao CT, Chen IH, Ng SH, Wang HM, Chang JT. (2014, 2) Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors. PLoS One. 24;9(2):e86922. 
  • 70. Tseng JR, Ho TY, Lin CY, Lee LY, Wang HM, Liao CT, Yen TC. (2013, 11) Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT. PLoS One. 11;8(11):e79766. SCI, Impact Factor: 2.776, Rank: 24/69.
  • 71. Chan SC*, Kuo WH, Wang HM, Chang JT, Lin CY, Ng SH, Hsu CL, Chang KP, Liao CT, Lin YJ, Yen TC. (2013, 10) Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Ann Nucl Med. 27(8):710-9.
  • 72. Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC*. (2013, 10) Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. J Nucl Med. 54(10):1703-9.
  • 73. Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM, Ng SH, Chang YL, Lai CH, Shih SR, Yen TC. (2013, 8) Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. J Clin Virol. 57(4):331-7. 
  • 74. Ng SH, Lin CY, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Huang SF, Lin YC, Wang JJ. (2013, 8) Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy. PLoS One. 8(8):e72230.
  • 75. Chen HH, Wang HM, Fan KH, Lin CY, Yen TC, Liao CT, Chen IH, Kang CJ, Huang SF. (2013, 8) Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma. PLoS One. 8(1):e55327.
  • 76. Chen SC, Lai YH, Liao CT, Chang JT, Lin CY, Fan KH, Huang BS. (2013, 6) Supportive care needs in newly diagnosed oral cavity cancer patients receiving radiation therapy. Psychooncology. 22(6):1220-8.
  • 77. Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, Huang SF, Tsang NM, Lee LY, Ng SH, Wang HM. (2013, 6) Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma. Oral Oncol. 49(6):620-5.
  • 78. Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Chang KP, Huang SF, Kang CJ, Fang KH, Wang YC, Chang YL, Huang YC, Tsai CY, Yen TC. (2013, 3) Comparative outcomes in oral cavity cancer with resected pT4a and pT4b. Oral Oncol. 49(3):230-6.
  • 79. Hung TM, Wang HM, Kang CJ, Huang SF, Liao CT, Chan SC, Ng SH, Chen IH, Lin CY, Fan KH, Chang JT. (2013, 2) Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma. Oral Oncol. 49(2):169-74. 
  • 80. Chen HH, Wang HM, Fan KH, Lin CY, Yen TC, Liao CT, Chen IH, Kang CJ, Huang SF. (2013, 2) Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma. PLoS One. 2013;8(1):e55327.
  • 81. Tsan DL, Lin CY, Kang CJ, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Wang HM, Chang JT*. (2012,12) The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity. Radiat Oncol. 18;7(1):215. 
  • 82. Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC. (2012, 11) Prognostic value of pretreatment (18)F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 39(11):1673-84.
  • 83. Chan SC, Wang HM, Ng SH, Hsu CL, Lin YJ, Lin CY, Liao CT, Yen TC. (2012, 11) Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients. J Nucl Med. 2012 Sep 7. 53(11):1730-5. 
  • 84. Huang SF, Wei FC, Liao CT, Wang HM, Lin CY, Lo S, Huang JJ, Chen IH, Kang CJ, Chien HT, Chen HH. (2012, 11) Risk Stratification in Oral Cavity Squamous Cell Carcinoma by Preoperative CRP and SCC Antigen Levels. Ann Surg Oncol. 19(12):3856-64. 
  • 85. Luo CM, Fang TJ, Lin CY, Chang JT, Liao CT, Chen IH, Li HY, Chiang HC. (2012, 9) Transoral Laser Microsurgery Elevates Fundamental Frequency in Early Glottic Cancer. J Voice. 26(5):596-601. 
  • 86. Hsu CL, Chang KP, Lin CY, Chang HK, Wang CH, Lin TL, Liao CT, Tsang NM, Lee LY, Chan SC, Ng SH, Li HP, Chang YS, Wang HM. (2012, 8) Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck. 34(8):1064-70.
  • 87. Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Yang SL, Tsao KC, Chang YL, Yen TC. (2012, 7) Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One. 2012;7(7):e40767. 
  • 88. Liao CT, Lin CY, Fan KH, Wang HM, Ng SH, Lee LY, Hsueh C, Chen IH, Huang SF, Kang CJ, Yen TC. (2012, 6) Identification of a High-Risk Group Among Patients With Oral Cavity Squamous Cell Carcinoma and pT1-2N0 Disease. Int J Radiat Oncol Biol Phys. 1;82(1):284-90.
  • 89. Kang CJ, Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Ng SH, Tsao CK, Huang YC, Yen TC. (2011, 11) Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma. Oral Oncol. 47(11):1085-91.
  • 90. Kang CJ, Lin CY, Wang HM, Fan KH, Ng SH, Lee LY, Chen IH, Huang SF, Liao CT, Yen TC.(2011, 11) The Number of Pathologically Positive Lymph Nodes and Pathological Tumor Depth Predicts Prognosis in Patients with Poorly Differentiated Squamous Cell Carcinoma of the Oral Cavity. Int J Radiat Oncol Biol Phys. 15;81(4):e223-30.
  • 91. Liao CT, Lee LY, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Yen TC. (2011, 11) Outcome Analysis of Patients with Oral Cavity Cancer and Extracapsular Spread in Neck Lymph Nodes. Int J Radiat Oncol Biol Phys. 15;81(4):930-7.
  • 92. Chan SC, Chang JT, Lin CY, Ng SH, Wang HM, Liao CT, Chang CJ, Lin SY, Yen TC. (2011, 11) Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification. Nucl Med Commun. 32(11):989-96.
  • 93. Liao CT, Lin CY, Fan KH, Huang SF, Chen IH, Kang CJ, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. (2011, 9) Identification of a High-Risk Subgroup of Patients with Resected pT3 Oral Cavity Cancer in Need of Postoperative Adjuvant Therapy. Ann Surg Oncol. 18(9):2569-78. 
  • 94. Chan SC, Wang HM, Yen TC, Lin CY, Chin SC, Liao CT, Wai YY, Wang JJ, Ng SH. (2011, 9) (18)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging. 38(9):1607-19. 
  • 95. Ng SH, Chan SC, Yen TC, Liao CT, Lin CY, Tung-Chieh Chang J, Ko SF, Wang HM, Chang KP, Fan KH. (2011, 6) PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma. Eur J Nucl Med Mol Imaging.38(6):996-1008.
  • 96. Abd El-Hafez YG, Chen CC, Ng SH, Lin CY, Wang HM, Chan SC, Chen IH, Huan SF, Kang CJ, Lee LY, Lin CH, Liao CT, Yen TC. (2011, 4) Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 47(4):288-95. 
  • 97. Liao CT, Wang HM, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. (2011, 2) PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med. 52(2):180-7.
  • 98. Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. (2010, 11) Tongue and Buccal Mucosa Carcinoma: Is There a Difference in Outcome? Ann Surg Oncol. 17:2984-91. 
  • 99. Chang MF, Wang HM, Kang CJ, Huang SF, Lin CY, Fang KH, Chen EY, Chen IH, Liao CT, Chang JT*. (2010, 10) Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan. Radiat Oncol. 5:91.
  • 100. Lin TY, Chang JT, Wang HM, Chan SH, Chiu CC, Lin CY, Fan KH, Liao CT, Chen IH, Liu TZ, Li HF, Cheng AJ.(2010, 9) Proteomics of the Radioresistant Phenotype in Head-and-Neck Cancer: Gp96 As a Novel Prediction Marker and Sensitizing Target for Radiotherapy. Int J Radiat Oncol Biol Phys. 78:246-56.
  • 101. Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Lin CY, Chang KP, Lin YC. (2010, 9) Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol. 20:2229-40. 
  • 102. Fan KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, Chen EY, Chen IH, Liao CT, Chang JT. (2010, 7) Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys. 77:1024-9. 
  • 103. Liao CT, Wang HM, Chang JT, Lin CY, Ng SH, Huang SF, Chen IH, Hsueh C, Lee LY, Lin CH, Cheng AJ, Yen TC. (2010, 6) Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 77:421-9.
  • 104. Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C, Lee LY, Tsao CK, Yen TC. (2010, 4) Outcome Analysis of Patients with pN2 Oral Cavity Cancer. Ann Surg Oncol. 17:1118-26.
  • 105. Chang JT, Lin CY, Lin JC, Lee MS, Chen YJ, Wang HM. (2010, 4) Transdermal Fentanyl for Pain Caused by Radiotherapy in Head and Neck Cancer Patients Treated in an Outpatient Setting: A Multicenter Trial in Taiwan. Jpn J Clin Oncol. 40:307-12. 
  • 106. Chan SC, Lin CY, Ng SH, Chang JT, Wang HM, Liao CT, Lo CW, Yen TC. (2010, 3) 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis. Nucl Med Commun. 31:260-5. 
  • 107. Wu YH, Wang HM, Hi-Wen Chen H, Lin CY, Yen-Chao Chen E, Fan KH, Huang SF, Chen IH, Liao CT, Cheng AJ, Chang JT. (2010, 3) Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 76:1133-9. 
  • 108. Kang CJ, Chen YJ, Liao CT, Wang HM, Chang JT, Lin CY, Lee LY, Wang TH, Yen TC, Shen CR, Chen IH, Chiu CC, Cheng AJ. (2009, 11) Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett. 284:131-40. 
  • 109. Hung TM, Hong JH, Leung WM, Lin CY, Tsan DL, Tsang NM*. (2009, 9) Radiation Therapy for Advanced Hepatocellular Carcinoma with Hepatic Hilum Involvement and High Bilirubin Level: Better Survival in Decreased Bilirubin after Radiotherapy. Therapeut Radiol Oncol 16(3) 179-194.
  • 110. Ng SH, Chan SC, Liao CT, Chang JT, Ko SF, Wang HM, Chin SC, Lin CY, Huang SF, Yen TC. (2008, 11) Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18) F-FDG PET and extended-field multi-detector row CT. Neuroradiology. 50:969-79.
  • 111. Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JT, Liao CT, Wang HM, Yen TC, Shen CR, Liao SK, Cheng AJ. (2008, 9) Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. Mol Cancer Ther. 7: 2788-97. SCI, Impact Factor: 2.504, Rank: 7/14. 
  • 112. Chang JT, Chang CH, Juang YY, Hsiao JC, Lin CY, Huang SF, Huang YC, Kuan KH, Liao CT, Wang HM, Chen IH. (2008, 7) Internal consistency of the traditional Chinese character version of the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N). Chang Gung Med J. 31(4):384-94.
  • 113. Chan SC, Chang JT, Wang HM, Lin CY, Ng SH, Fan KH, Chin SC, Liao CT, Yen TC. (2008, 5) Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value. Oral Oncol. 45:52-8.
  • 114. Huang SF, Kang CJ, Lin CY, Fan KH, Yen TC, Wang HM, Chen IH, Liao CT, Cheng AJ, Chang JT. (2008, 3) Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer. 112: 1066-75.
  • 115. Liu FY, Lin CY, Chang JT, Ng SH, Chin SC, Wang HM, Liao CT, Chan SC, Yen TC. (2007, 10) 18F-FDG PET Can Replace Conventional Work-up in Primary M Staging of Nonkeratinizing Nasopharyngeal Carcinoma. J Nucl Med. 48:1614-1619.
  • 116. Chang JT, Chen CJ, Lin YC, Chen YC, Lin CY, Cheng AJ. (2007, 9) Health-related quality of life and patient satisfaction after treatment for breast cancer in northern Taiwan. Int J Radiat Oncol Biol Phys. 69:49-53. 
  • 117. Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, Wang TH, Lee LY, Cheng AJ. (2007, 8) Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther. 6: 2271-9. 
  • 118. Fan KH, Lin CY, Kang CJ, Huang SF, Wang HM, Chen EY, Chen IH, Liao CT, Cheng AJ, Chang JT. (2007, 2) Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 67: 453-61. 
  • 119. Chan SC, Yen TC, Ng SH, Lin CY, Wang HM, Liao CT, Fan KH, Chang JT. (2006, 9) Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management. J Nucl Med. 47:1447-54.
  • 120. Chan SC, Ng SH, Chang JT, Lin CY, Chen YC, Chang YC, Hsu CL, Wang HM, Liao CT, Yen TC. (2006, 9) Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 33: 1032-40. 
  • 121. Yen TC, Lin CY, Wang HM, Huang SF, Liao CT, Kang CJ, Ng SH, Chan SC, Fan KH, Chen IH, Lin WJ, Cheng AJ, Chang JT. (2006, 2) 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity modulated radiation technique for stage T4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 65:1307-14. 
  • 122. Chang JT, Lin CY, Chen TM, Kang CJ, Ng SH, Chen IH, Wang HM, Cheng AJ, Liao CT. (2005, 12) Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy. Int J Radiat Oncol Biol Phys. 63:1354-60.
  • 123. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY. (2005, 3). The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 46:405-10. 
  • 124. Chang JT, Chan SC, Yen TC, Liao CT, Lin CY, Chen IH, Wang HM, Chang YC, Chen TM, Kang CJ, Ng SH. (2005, 1) Nasopharyngeal carcinoma staging PDG PET. Int J Radiat Oncol Biol Phys 30:501-06. 
  • 125. Liao CT, Chang JT, Wang HM, Chen IH, Lin CY, Chen TM, Hsieh LL, Cheng AJ. (2004, 6) Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck. 26: 504-12. 
  • 126. Tsang NM, Chuang CC, Tseng CK, Hao SP, Kuo TT, Lin CY, Pai PC. (2003, 9) Presence of the latent membrane protein 1 Gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma. Cancer. 98: 2385-92.
  • 127. Tsang NM, Fan KH, Pai PC, Tsai CS, Lin CY, Chen CY, Tseng CK. (2003, 3) The Effect of Fixed Couch-Isocenter Distance Treatment on Radiotherapy in Rectal Cancer Patients. Therapeut Radiol Oncol 10:1, 37-44. 
  • 128. Huang YT, Pai PC, Tseng CK, Lin CY, Hong JH, Tsang NM. (2003, 6) The outcome of patients with nasopharyngeal carcinoma treated with suboptimal radiation dose. Therapeut Radiol Oncol 10:2:63-68.